Singapore markets closed

Collegium Pharmaceutical, Inc. (COLL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
36.42+0.58 (+1.62%)
At close: 04:00PM EDT
36.42 0.00 (0.00%)
After hours: 05:32PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close35.84
Open35.95
Bid36.35 x 200
Ask36.46 x 200
Day's range35.79 - 36.57
52-week range20.83 - 40.95
Volume121,316
Avg. volume410,536
Market cap1.191B
Beta (5Y monthly)1.04
PE ratio (TTM)28.23
EPS (TTM)1.29
Earnings date09 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est40.00
  • GlobeNewswire

    Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

    STOUGHTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report first quarter 2024 financial results after the market closes on Thursday, May 9, 2024. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET. Conference Call Informa

  • Simply Wall St.

    Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 25% Impressive?

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

  • GlobeNewswire

    Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

    STOUGHTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) (the “Company”), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it has called all $26,350,000 aggregate principal amount of its outstanding 2.625% Convertible Senior Notes Due 2026 (the “Notes”) (CUSIP No. 19459JAA2; ISIN No. US19459JAA25) for redemption on Friday, June 14, 2024 (the “Re